Wayland Group Financials
| MRRCF Stock | USD 0.0001 0.00 0.00% |
Wayland |
Understanding current and past Wayland Group Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Wayland Group's financial statements are interrelated, with each one affecting the others. For example, an increase in Wayland Group's assets may result in an increase in income on the income statement.
Wayland Group Stock Summary
Wayland Group competes with CbdMD, Evolus, Akanda Corp, Biofrontera, and Collegium Pharmaceutical. Wayland Group Corp. produces and sells medical and non-medical cannabis for cannabis patients and consumers in Canada and internationally. The company was founded in 2013 and is headquartered in Oakville, Canada. WAYLAND GROUP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 68 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 2381 Bristol Circle, |
| Sector | Healthcare |
| Industry | Drug Manufacturers—Specialty & Generic |
| Benchmark | Dow Jones Industrial |
| Website | www.waylandgroup.com |
| Phone | 289 288 6274 |
| Currency | USD - US Dollar |
Wayland Group Key Financial Ratios
There are many critical financial ratios that Wayland Group's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Wayland Group Corp reports annually and quarterly.Wayland Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Wayland Group's current stock value. Our valuation model uses many indicators to compare Wayland Group value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Wayland Group competition to find correlations between indicators driving Wayland Group's intrinsic value. More Info.Wayland Group Corp is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Wayland Group's earnings, one of the primary drivers of an investment's value.Wayland Group Corp Systematic Risk
Wayland Group's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Wayland Group volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Wayland Group Corp correlated with the market. If Beta is less than 0 Wayland Group generally moves in the opposite direction as compared to the market. If Wayland Group Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Wayland Group Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Wayland Group is generally in the same direction as the market. If Beta > 1 Wayland Group moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Wayland Pink Sheet analysis
When running Wayland Group's price analysis, check to measure Wayland Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Wayland Group is operating at the current time. Most of Wayland Group's value examination focuses on studying past and present price action to predict the probability of Wayland Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Wayland Group's price. Additionally, you may evaluate how the addition of Wayland Group to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |